Treatment of LNCaP but not PC3 prostate cancer cells with forskolin or cAMP causes Rap1 phosphorylation and activation by protein kinase A (PKA) [36], and activated Rap1 has been shown to induce the MAPK pathway by stimulating B-Raf [37], [38]. This evidence concerns the gene BRAF and prostate carcinoma.